Inhibitors for the blood-clotting factor xa

Details for Australian Patent Application No. 2001281843 (hide)

Owner Curacyte AG

Inventors Schweinitz, Andrea; Kunzel, Sebastian; Steinmetzer, Torsten; Sturzebecher, Jorg

Agent Watermark

Pub. Number AU-B-2001281843

PCT Pub. Number WO01/96366

Priority 10029015 15.06.00 DE

Filing date 15 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 9 June 2005

International Classifications

C07K 005/06 Peptides having up to four amino acids in a fully defined sequence

C07C 257/00 Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines

A61K 038/04 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

Event Publications

9 June 2005 Application Accepted

  Published as AU-B-2001281843

6 October 2005 Standard Patent Sealed

6 October 2005 Corrigenda

  Applications Accepted - Name Index Under the name Curacyte AG, Application No. 2001281843, under INID (54) correct the title to read Dipeptide inhibitors for the blood-clotting factor Xa.

31 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001281845-Switch device for an electrical appliance

2001281842